Pharma & Healthcare
Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Research Report 2026
- Feb 24, 26
- ID: 720371
- Pages: 101
- Figures: 103
- Views: 1
This report delivers a comprehensive overview of the global N-Acetylglutamate Synthetase Deficiency (NAGSD) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding N-Acetylglutamate Synthetase Deficiency (NAGSD). The N-Acetylglutamate Synthetase Deficiency (NAGSD) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global N-Acetylglutamate Synthetase Deficiency (NAGSD) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist N-Acetylglutamate Synthetase Deficiency (NAGSD) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Recordati Rare Diseases
Grand Pharmaceutical Group
Sovereign Medical
Lee's Pharmaceuticals
Medunik
Acer Therapeutics
Sigmapharm Laboratories
Amgen
Immedica
Segment by Type
Original Drug
Generic Drug
Segment by Application
Adults
Children
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for N-Acetylglutamate Synthetase Deficiency (NAGSD) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global N-Acetylglutamate Synthetase Deficiency (NAGSD) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist N-Acetylglutamate Synthetase Deficiency (NAGSD) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Recordati Rare Diseases
Grand Pharmaceutical Group
Sovereign Medical
Lee's Pharmaceuticals
Medunik
Acer Therapeutics
Sigmapharm Laboratories
Amgen
Immedica
Segment by Type
Original Drug
Generic Drug
Segment by Application
Adults
Children
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for N-Acetylglutamate Synthetase Deficiency (NAGSD) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Adults
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Perspective (2021–2032)
2.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Growth Trends by Region
2.2.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 N-Acetylglutamate Synthetase Deficiency (NAGSD) Historic Market Size by Region (2021–2026)
2.2.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Region (2027–2032)
2.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Dynamics
2.3.1 N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Trends
2.3.2 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Drivers
2.3.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Challenges
2.3.4 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top N-Acetylglutamate Synthetase Deficiency (NAGSD) Players by Revenue
3.1.1 Global Top N-Acetylglutamate Synthetase Deficiency (NAGSD) Players by Revenue (2021–2026)
3.1.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Players (2021–2026)
3.2 Global Top N-Acetylglutamate Synthetase Deficiency (NAGSD) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue
3.4 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Concentration Ratio
3.4.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue in 2025
3.5 Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD) Head Offices and Areas Served
3.6 Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD), Products and Applications
3.7 Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 N-Acetylglutamate Synthetase Deficiency (NAGSD) Breakdown Data by Type
4.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Historic Market Size by Type (2021–2026)
4.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Type (2027–2032)
5 N-Acetylglutamate Synthetase Deficiency (NAGSD) Breakdown Data by Application
5.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Historic Market Size by Application (2021–2026)
5.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021–2032)
6.2 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021–2026)
6.4 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021–2032)
7.2 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021–2026)
7.4 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021–2032)
8.2 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021–2026)
8.4 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021–2032)
9.2 Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021–2026)
9.4 Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021–2032)
10.2 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021–2026)
10.4 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Recordati Rare Diseases
11.1.1 Recordati Rare Diseases Company Details
11.1.2 Recordati Rare Diseases Business Overview
11.1.3 Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.1.4 Recordati Rare Diseases Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.1.5 Recordati Rare Diseases Recent Development
11.2 Grand Pharmaceutical Group
11.2.1 Grand Pharmaceutical Group Company Details
11.2.2 Grand Pharmaceutical Group Business Overview
11.2.3 Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.2.4 Grand Pharmaceutical Group Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.2.5 Grand Pharmaceutical Group Recent Development
11.3 Sovereign Medical
11.3.1 Sovereign Medical Company Details
11.3.2 Sovereign Medical Business Overview
11.3.3 Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.3.4 Sovereign Medical Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.3.5 Sovereign Medical Recent Development
11.4 Lee's Pharmaceuticals
11.4.1 Lee's Pharmaceuticals Company Details
11.4.2 Lee's Pharmaceuticals Business Overview
11.4.3 Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.4.4 Lee's Pharmaceuticals Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.4.5 Lee's Pharmaceuticals Recent Development
11.5 Medunik
11.5.1 Medunik Company Details
11.5.2 Medunik Business Overview
11.5.3 Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.5.4 Medunik Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.5.5 Medunik Recent Development
11.6 Acer Therapeutics
11.6.1 Acer Therapeutics Company Details
11.6.2 Acer Therapeutics Business Overview
11.6.3 Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.6.4 Acer Therapeutics Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.6.5 Acer Therapeutics Recent Development
11.7 Sigmapharm Laboratories
11.7.1 Sigmapharm Laboratories Company Details
11.7.2 Sigmapharm Laboratories Business Overview
11.7.3 Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.7.4 Sigmapharm Laboratories Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.7.5 Sigmapharm Laboratories Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.8.4 Amgen Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.8.5 Amgen Recent Development
11.9 Immedica
11.9.1 Immedica Company Details
11.9.2 Immedica Business Overview
11.9.3 Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.9.4 Immedica Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.9.5 Immedica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Adults
1.3.3 Children
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Perspective (2021–2032)
2.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Growth Trends by Region
2.2.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 N-Acetylglutamate Synthetase Deficiency (NAGSD) Historic Market Size by Region (2021–2026)
2.2.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Region (2027–2032)
2.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Dynamics
2.3.1 N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Trends
2.3.2 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Drivers
2.3.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Challenges
2.3.4 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top N-Acetylglutamate Synthetase Deficiency (NAGSD) Players by Revenue
3.1.1 Global Top N-Acetylglutamate Synthetase Deficiency (NAGSD) Players by Revenue (2021–2026)
3.1.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Players (2021–2026)
3.2 Global Top N-Acetylglutamate Synthetase Deficiency (NAGSD) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue
3.4 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Concentration Ratio
3.4.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue in 2025
3.5 Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD) Head Offices and Areas Served
3.6 Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD), Products and Applications
3.7 Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 N-Acetylglutamate Synthetase Deficiency (NAGSD) Breakdown Data by Type
4.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Historic Market Size by Type (2021–2026)
4.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Type (2027–2032)
5 N-Acetylglutamate Synthetase Deficiency (NAGSD) Breakdown Data by Application
5.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Historic Market Size by Application (2021–2026)
5.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021–2032)
6.2 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021–2026)
6.4 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021–2032)
7.2 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021–2026)
7.4 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021–2032)
8.2 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021–2026)
8.4 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021–2032)
9.2 Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021–2026)
9.4 Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021–2032)
10.2 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021–2026)
10.4 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Recordati Rare Diseases
11.1.1 Recordati Rare Diseases Company Details
11.1.2 Recordati Rare Diseases Business Overview
11.1.3 Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.1.4 Recordati Rare Diseases Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.1.5 Recordati Rare Diseases Recent Development
11.2 Grand Pharmaceutical Group
11.2.1 Grand Pharmaceutical Group Company Details
11.2.2 Grand Pharmaceutical Group Business Overview
11.2.3 Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.2.4 Grand Pharmaceutical Group Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.2.5 Grand Pharmaceutical Group Recent Development
11.3 Sovereign Medical
11.3.1 Sovereign Medical Company Details
11.3.2 Sovereign Medical Business Overview
11.3.3 Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.3.4 Sovereign Medical Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.3.5 Sovereign Medical Recent Development
11.4 Lee's Pharmaceuticals
11.4.1 Lee's Pharmaceuticals Company Details
11.4.2 Lee's Pharmaceuticals Business Overview
11.4.3 Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.4.4 Lee's Pharmaceuticals Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.4.5 Lee's Pharmaceuticals Recent Development
11.5 Medunik
11.5.1 Medunik Company Details
11.5.2 Medunik Business Overview
11.5.3 Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.5.4 Medunik Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.5.5 Medunik Recent Development
11.6 Acer Therapeutics
11.6.1 Acer Therapeutics Company Details
11.6.2 Acer Therapeutics Business Overview
11.6.3 Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.6.4 Acer Therapeutics Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.6.5 Acer Therapeutics Recent Development
11.7 Sigmapharm Laboratories
11.7.1 Sigmapharm Laboratories Company Details
11.7.2 Sigmapharm Laboratories Business Overview
11.7.3 Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.7.4 Sigmapharm Laboratories Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.7.5 Sigmapharm Laboratories Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.8.4 Amgen Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.8.5 Amgen Recent Development
11.9 Immedica
11.9.1 Immedica Company Details
11.9.2 Immedica Business Overview
11.9.3 Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Introduction
11.9.4 Immedica Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
11.9.5 Immedica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Original Drug
Table 3. Key Players of Generic Drug
Table 4. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (US$ Million), 2021–2026
Table 7. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region (2021–2026)
Table 8. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region (2027–2032)
Table 10. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Trends
Table 11. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Drivers
Table 12. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Challenges
Table 13. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Restraints
Table 14. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue by Players (US$ Million), 2021–2026
Table 15. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Players (2021–2026)
Table 16. Global Top N-Acetylglutamate Synthetase Deficiency (NAGSD) Players by Tier (Tier 1, Tier 2, and Tier 3), based on N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, 2025
Table 17. Ranking of Global Top N-Acetylglutamate Synthetase Deficiency (NAGSD) Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD), Headquarters and Area Served
Table 20. Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD), Products and Applications
Table 21. Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD), Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (US$ Million), 2021–2026
Table 24. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Type (2021–2026)
Table 25. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Type (2027–2032)
Table 27. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (US$ Million), 2021–2026
Table 28. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Application (2021–2026)
Table 29. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Application (2027–2032)
Table 31. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2021–2026
Table 33. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2027–2032
Table 34. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2021–2026
Table 36. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2027–2032
Table 46. Recordati Rare Diseases Company Details
Table 47. Recordati Rare Diseases Business Overview
Table 48. Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 49. Recordati Rare Diseases Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 50. Recordati Rare Diseases Recent Development
Table 51. Grand Pharmaceutical Group Company Details
Table 52. Grand Pharmaceutical Group Business Overview
Table 53. Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 54. Grand Pharmaceutical Group Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 55. Grand Pharmaceutical Group Recent Development
Table 56. Sovereign Medical Company Details
Table 57. Sovereign Medical Business Overview
Table 58. Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 59. Sovereign Medical Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 60. Sovereign Medical Recent Development
Table 61. Lee's Pharmaceuticals Company Details
Table 62. Lee's Pharmaceuticals Business Overview
Table 63. Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 64. Lee's Pharmaceuticals Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 65. Lee's Pharmaceuticals Recent Development
Table 66. Medunik Company Details
Table 67. Medunik Business Overview
Table 68. Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 69. Medunik Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 70. Medunik Recent Development
Table 71. Acer Therapeutics Company Details
Table 72. Acer Therapeutics Business Overview
Table 73. Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 74. Acer Therapeutics Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 75. Acer Therapeutics Recent Development
Table 76. Sigmapharm Laboratories Company Details
Table 77. Sigmapharm Laboratories Business Overview
Table 78. Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 79. Sigmapharm Laboratories Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 80. Sigmapharm Laboratories Recent Development
Table 81. Amgen Company Details
Table 82. Amgen Business Overview
Table 83. Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 84. Amgen Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 85. Amgen Recent Development
Table 86. Immedica Company Details
Table 87. Immedica Business Overview
Table 88. Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 89. Immedica Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 90. Immedica Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report
List of Figures
Figure 1. N-Acetylglutamate Synthetase Deficiency (NAGSD) Picture
Figure 2. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Type: 2025 vs 2032
Figure 4. Original Drug Features
Figure 5. Generic Drug Features
Figure 6. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (US$ Million), 2021–2032
Figure 7. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Application: 2025 vs 2032
Figure 8. Adults Case Studies
Figure 9. Children Case Studies
Figure 10. N-Acetylglutamate Synthetase Deficiency (NAGSD) Report Years Considered
Figure 11. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region: 2025 vs 2032
Figure 14. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Players in 2025
Figure 15. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue in 2025
Figure 17. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021–2032)
Figure 19. United States N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021–2032)
Figure 23. Germany N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region (2021–2032)
Figure 31. China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021–2032)
Figure 39. Mexico N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021–2032)
Figure 43. Israel N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Recordati Rare Diseases Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 47. Grand Pharmaceutical Group Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 48. Sovereign Medical Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 49. Lee's Pharmaceuticals Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 50. Medunik Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 51. Acer Therapeutics Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 52. Sigmapharm Laboratories Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 53. Amgen Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 54. Immedica Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Original Drug
Table 3. Key Players of Generic Drug
Table 4. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (US$ Million), 2021–2026
Table 7. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region (2021–2026)
Table 8. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region (2027–2032)
Table 10. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Trends
Table 11. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Drivers
Table 12. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Challenges
Table 13. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Restraints
Table 14. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue by Players (US$ Million), 2021–2026
Table 15. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Players (2021–2026)
Table 16. Global Top N-Acetylglutamate Synthetase Deficiency (NAGSD) Players by Tier (Tier 1, Tier 2, and Tier 3), based on N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, 2025
Table 17. Ranking of Global Top N-Acetylglutamate Synthetase Deficiency (NAGSD) Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD), Headquarters and Area Served
Table 20. Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD), Products and Applications
Table 21. Global Key Players of N-Acetylglutamate Synthetase Deficiency (NAGSD), Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (US$ Million), 2021–2026
Table 24. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Type (2021–2026)
Table 25. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Type (2027–2032)
Table 27. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (US$ Million), 2021–2026
Table 28. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Application (2021–2026)
Table 29. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Application (2027–2032)
Table 31. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2021–2026
Table 33. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2027–2032
Table 34. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2021–2026
Table 36. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (US$ Million), 2027–2032
Table 46. Recordati Rare Diseases Company Details
Table 47. Recordati Rare Diseases Business Overview
Table 48. Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 49. Recordati Rare Diseases Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 50. Recordati Rare Diseases Recent Development
Table 51. Grand Pharmaceutical Group Company Details
Table 52. Grand Pharmaceutical Group Business Overview
Table 53. Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 54. Grand Pharmaceutical Group Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 55. Grand Pharmaceutical Group Recent Development
Table 56. Sovereign Medical Company Details
Table 57. Sovereign Medical Business Overview
Table 58. Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 59. Sovereign Medical Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 60. Sovereign Medical Recent Development
Table 61. Lee's Pharmaceuticals Company Details
Table 62. Lee's Pharmaceuticals Business Overview
Table 63. Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 64. Lee's Pharmaceuticals Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 65. Lee's Pharmaceuticals Recent Development
Table 66. Medunik Company Details
Table 67. Medunik Business Overview
Table 68. Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 69. Medunik Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 70. Medunik Recent Development
Table 71. Acer Therapeutics Company Details
Table 72. Acer Therapeutics Business Overview
Table 73. Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 74. Acer Therapeutics Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 75. Acer Therapeutics Recent Development
Table 76. Sigmapharm Laboratories Company Details
Table 77. Sigmapharm Laboratories Business Overview
Table 78. Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 79. Sigmapharm Laboratories Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 80. Sigmapharm Laboratories Recent Development
Table 81. Amgen Company Details
Table 82. Amgen Business Overview
Table 83. Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 84. Amgen Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 85. Amgen Recent Development
Table 86. Immedica Company Details
Table 87. Immedica Business Overview
Table 88. Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Product
Table 89. Immedica Revenue in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (US$ Million), 2021–2026
Table 90. Immedica Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
Table 94. Authors List of This Report
List of Figures
Figure 1. N-Acetylglutamate Synthetase Deficiency (NAGSD) Picture
Figure 2. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Type: 2025 vs 2032
Figure 4. Original Drug Features
Figure 5. Generic Drug Features
Figure 6. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (US$ Million), 2021–2032
Figure 7. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Application: 2025 vs 2032
Figure 8. Adults Case Studies
Figure 9. Children Case Studies
Figure 10. N-Acetylglutamate Synthetase Deficiency (NAGSD) Report Years Considered
Figure 11. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region: 2025 vs 2032
Figure 14. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Players in 2025
Figure 15. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue in 2025
Figure 17. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021–2032)
Figure 19. United States N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021–2032)
Figure 23. Germany N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region (2021–2032)
Figure 31. China N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021–2032)
Figure 39. Mexico N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021–2032)
Figure 43. Israel N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Recordati Rare Diseases Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 47. Grand Pharmaceutical Group Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 48. Sovereign Medical Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 49. Lee's Pharmaceuticals Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 50. Medunik Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 51. Acer Therapeutics Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 52. Sigmapharm Laboratories Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 53. Amgen Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 54. Immedica Revenue Growth Rate in N-Acetylglutamate Synthetase Deficiency (NAGSD) Business (2021–2026)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232